title: Can we improve the prevention and detection of congenital abnormalities? An audit of early pregnancy care in New Zealand.
abstract: OBJECTIVE
  To determine whether there were "quality gaps" in the provision of care during pregnancies that resulted in a perinatal death due to congenital abnormality.
  
  
  METHODS
  Perinatal deaths from congenital cardiovascular, central nervous system or chromosomal abnormality in 2010 were identified retrospectively. Data were extracted by retrospective clinical note review and obtained by independent review of ultrasound scans.
  
  
  RESULTS
  There were 137 perinatal deaths due to a congenital cardiovascular (35), central nervous system (29) or chromosomal abnormality (73). First contact with a health professional during pregnancy was predominantly with a general practitioner. First contact occurred within 14 weeks in 85% of pregnancies and there was often a significant delay before booking. Folate supplements were taken by 7% pre-conceptually and 54% of women in the antenatal period. There were 20 perinatal deaths from neural tube defects that could potentially have been prevented through the use of pre-conceptual folate. Antenatal screening was offered to 75% of the women who presented prior to 20 weeks and 84% of these undertook at least one of the available antenatal screening tests. Review of ultrasound images found five abnormalities could have been detected earlier.
  
  
  CONCLUSIONS
  Delay in booking or failure to offer screening early were the most common reasons for delay in diagnosis of screen detectable abnormalities. The preventative value and timing of (pre-conceptual) folate needs emphasis.
authors.affiliation: The University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand. c.farquhar@auckland.ac.nz.
authors.forename: Nicola
authors.initials: N
authors.lastname: Arroll
authors.forename: Lynn
authors.initials: L
authors.lastname: Sadler
authors.forename: Peter
authors.initials: P
authors.lastname: Stone
authors.forename: Vicki
authors.initials: V
authors.lastname: Masson
authors.forename: Cindy
authors.initials: C
authors.lastname: Farquhar
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000151:congenital / Q000000981:diagnostic imaging / Q000401:mortality; D002493:Central Nervous System Diseases / Q000151:congenital / Q000000981:diagnostic imaging / Q000401:mortality; D002869:Chromosome Aberrations; D000013:Congenital Abnormalities / Q000000981:diagnostic imaging* / Q000401:mortality*; D005260:Female; D005313:Fetal Death; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D009520:New Zealand / Q000453:epidemiology; D011247:Pregnancy; D011295:Prenatal Care; D012189:Retrospective Studies; D012307:Risk Factors; D016216:Ultrasonography, Prenatal
chemical_list: D005492:Folic Acid